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Purpose. To investigate the eﬃcacy of recombinant human collagen type I (RHC I) and collagen-like peptide (CLP)
hydrogels as alternative carrier substrates for the cultivation of limbal epithelial stem cells (LESC) under xeno-free
culture conditions. Methods. Human LESC were cultivated on seven diﬀerent collagen-derived hydrogels: (1) unmodiﬁed
RHC I, (2) ﬁbronectin-patterned RHC I, (3) carbodiimide-crosslinked CLP (CLP-12 EDC), (4) DMTMM-
(4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium-) crosslinked CLP (CLP-12), (5) ﬁbronectin-patterned CLP-12,
(6) “3D limbal niche-mimicking” CLP-12, and (7) DMTMM-crosslinked CLP made from higher CLP concentration solution.
Cell proliferation, cell morphology, and expression of LESC markers were analyzed. All data were compared to cultures on
human amniotic membrane (HAM). Results. Human LESC were successfully cultivated on six out of seven hydrogel
formulations, with primary cell cultures on CLP-12 EDC being deemed unsuccessful since the area of outgrowth did not meet
quality standards (i.e., inconsistence in outgrowth and conﬂuence) after 14 days of culture. Upon conﬂuence, primary LESC
showed high expression of the stem cell marker ΔNp63, proliferation marker cytokeratin (KRT) 14, adhesion markers
integrin-β4 and E-cadherin, and LESC-speciﬁc extracellular matrix proteins laminin-α1, and collagen type IV. Cells showed low
expression of diﬀerentiation markers KRT3 and desmoglein 3 (DSG3). Signiﬁcantly higher gene expression of KRT3 was
observed for cells cultured on CLP hydrogels compared to RHC I and HAM. Surface patterning of hydrogels inﬂuenced the
pattern of proliferation but had no signiﬁcant eﬀect on the phenotype or genotype of cultures. Overall, the performance of RHC
I and DMTMM-crosslinked CLP hydrogels was equivalent to that of HAM. Conclusion. RHC I and DMTMM-crosslinked CLP
hydrogels, irrespective of surface modiﬁcation, support successful cultivation of primary human LESC using a xeno-free
cultivation protocol. The regenerated epithelium maintained similar characteristics to HAM-based cultures.
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1. Introduction
Located at the corneoscleral limbus, limbal epithelial stem
cells (LESC) play a pivotal role in rejuvenating the corneal
epithelium and keeping the cornea healthy, transparent,
and avascular [1, 2]. Damage to the LESC or their stem cell
niche may lead to limbal stem cell deﬁciency (LSCD). This
condition is characterized by conjunctivalization and cicatri-
zation of the cornea and may result in reduced vision, pain,
and photophobia [3]. Historically, surgical treatment of
patients suﬀering from LSCD includes conjunctival limbal
grafting or keratolimbal allografting.
Since its introduction in 1997 [4], cultivated limbal epi-
thelial transplantation (CLET) has shown to be an eﬀective
therapy for LSCD, with clinical trials reporting an average
success rate of 70% [5]. In CLET, a small limbal biopsy is cul-
tivated ex vivo on a stem cell carrier, after which cultured
cells are grafted into the patient’s diseased eye. The stem cell
carrier most frequently used in these trials is the human
amniotic membrane (HAM). Harvested by caesarian section,
HAM has been used for many years in ocular surgery [6, 7]. It
has the advantage of having anti-inﬂammatory, antimicro-
bial, and antiangiogenic properties [7, 8]. However, being a
biological membrane, procurement of HAM requires costly
donor screening for potential infectious pathogens [9]. In
addition, standardization of HAM procedures is diﬃcult
due to inter- and intradonor variabilities in membrane thick-
ness, mechanical properties, optical characteristics, and
growth factor release [10–13]. Furthermore, in vitro process-
ing remains labor intensive, costly, and challenging [9].
These limitations hamper the application of HAM in ocular
tissue engineering. Other stem cell carriers such as ﬁbrin
and siloxane hydrogel contact lenses have been used in
human clinical trials [5]. In 2015, Holoclar® (Chiesi, Italy),
a technique in which limbal cells are expanded on ﬁbrin scaf-
folds, was conditionally approved for release in Europe as the
ﬁrst commercially available stem cell therapy for LSCD. Nev-
ertheless, use of this medicinal product is restricted to autol-
ogous stem cell transplantation in unilateral cases after
chemical or thermal burn. Furthermore, ﬁbrin hydrogels
require the application of xenogenic culture protocols that
involve murine 3T3 feeder layers, which brings into question
safety of the end-product. Therefore, a safe and standardized
therapy that targets all LSCD patients has yet to be
developed.
Various biomaterials have been proposed as alternative
carriers to the use of HAM and ﬁbrin in corneal tissue engi-
neering [5, 14]. A promising approach is the application of
collagen hydrogels, as these are characterized by inherent
biocompatibility and cost eﬀectiveness [15, 16]. In 2009, the
group of Fagerholm et al. were the ﬁrst to report the success-
ful implantation of acellular recombinant human collagen
type III (RHC III) hydrogels, crosslinked by 1-ethyl-3-(3-di-
methyl aminopropyl) carbodiimide/N-hydroxysuccinimide
(EDC/NHS), as corneal stromal substitutes in humans [17].
In subsequent reports, RHC III-based hydrogels were
implanted in 20 patients, with collagen being sourced from
yeast in each of these cases [18–20]. After surgery,
implants supported full epithelial regeneration, though slow
reepithelialization rates could be noted, with full epithelial
regeneration taking up to one year [20]. Additional explora-
tion of RHC III-based hydrogels showed that surface modiﬁ-
cation, by means of ﬁbronectin microcontact printing
(F-μCP), improved reepithelialization rates in vitro [21].
Even though F-μCP of RHC III implants has yet to be vali-
dated in vivo, these results indicate the potential of surface
modiﬁcation in collagen-based corneal regeneration.
In recent years, alternative collagen sources have shown
great promise in tissue engineering, including fully synthetic
collagen-like peptide (CLP) and plant-derived RHC type I
(RHC I) [22–25]. CLP [26] was introduced as a shorter and
fully customizable alternative to RHC III peptide. As a syn-
thetic peptide, CLPmakes room for ready and scaled-up pro-
duction. When tested as a corneal construct in an animal
model, CLP proved to be functionally equivalent to RHC
III, except for mechanical strength for which CLP underper-
formed [27, 28]. These reports provide a proof-of-principle
and indicate that it is worthwhile exploring the versatility of
CLP hydrogels as a scaﬀold for LESC cultivation.
Another type of collagen that recently became available
is tobacco plant-derived RHC I [25]. Even though
plant-derived RHC I has shown promise in experimental
skin engineering and drug delivery [22, 29, 30], its applica-
tion in ocular tissue engineering remains to be validated.
Previous research compared the in vitro and in vivo per-
formance of yeast-extracted RHC I and RHC III corneal
constructs and concluded that both materials perform
fairly similarly, thoughRHC III displayedmarginally superior
mechanical properties [31, 32]. These results, in combination
with collagen type I being the most abundant protein of the
native corneal stroma [33], suggest that plant-derived RHC I
might oﬀer greater potential in ocular tissue engineering.
Our previous research demonstrated that plant-derived
RHC I hydrogels are mechanically stable, transparent, and
nongenotoxic and show good biocompatibility in vitro and
in vivo. Even though plant-derived RHC I and CLP hydrogels
appear promising substrates, both materials remain to be
validated as carrier membranes for LESC cultivation.
Therefore, the aim of this study was to investigate in vitro
performance of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4--
methyl-morpholinium chloride- (DMTMM-) crosslinked
CLP hydrogels, EDC/NHS-crosslinked CLP hydrogels, and
EDC/NHS-crosslinked plant-derived RHC I hydrogels with
regard to immortalized human corneal epithelial cell
(iHCEC) and primary human limbal epithelial cell cultiva-
tion. The eﬀect of surface topography and patterning was
investigated for both hydrogels. All data were compared to
HAM, the current gold standard in CLET.
2. Materials and Methods
The study followed the tenets of the Declaration of Helsinki
and was approved by the Antwerp University Hospital-
Ethical Committee (EC: 14/30/319).
2.1. Materials. Plant-derived RHC I and PEGylated CLP
were provided by Collplant (Ness Ziona, Israel) and
Ferentis (Vilnius, Lithuania), respectively. Laboratory
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plastic was purchased from VWR (Radnor, PA, USA),
Greiner Bio-One (Kremsmünster, Austria), or PerkinElmer
(Waltham, MA, USA). Unless stated otherwise, all inorganic
salts, enzymes, basic chemicals, Triton X, 4′,6-diamidi-
no-2-fenylindool (DAPI), N-hydroxysuccinimide (NHS),
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydro-
chloride (EDC), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4--
methylmorpholinium chloride (DMTMM), and CellCrown
inserts were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Materials obtained from Thermo Fisher Scientiﬁc
(Waltham) include phosphate-buﬀered saline (PBS), Presto-
Blue, Dulbecco’s modiﬁed Eagle’s medium (DMEM), kerati-
nocyte serum-free medium, Live/Dead staining kit, Alexa
Fluor® 568 hydrazide sodium salt, antibiotics, glycerol, and
UltraPure distilled water (DW). Optimum cutting temper-
ature (OCT) formulation was purchased from Sakura
Finetek Europe (Zoeterwoude, the Netherlands); nitrocel-
lulose paper and ﬁlter sterilizers were from Merck Millipore
(Darmstadt, Germany); polydimethylsiloxane (PDMS) was
from Dow Corning (Midland, MI, USA); balanced salt solu-
tion (BSS) was from Alcon (Fort Worth, TX, USA);
CnT-prime medium (CnT-PR) was from CELLnTEC (Bern,
Switzerland); PBS/glycerol Citiﬂuor was from Citiﬂuor Ltd.
(London, UK); and RNeasy Mini Kit was from QIAGEN
(Hilden, Germany). Human blood ﬁbronectin was obtained
through YO Proteins AB (Huddinge, Sweden) whereas
bovine ﬁbronectin was delivered by Cytoskeleton Inc.
(Denver, CO, USA). iScript™ Advanced cDNA Synthesis
kit, SsoAdvanced™ Universal SYBR® Green Supermix,
and oligonucleotide primers were obtained from Bio-Rad
(Hercules, CA, USA), unless stated otherwise. ΔNp63α
primer was purchased from Eurogentec (Liege, Belgium)
(Table 1). Antibodies used for immunohistochemistry and
its dilutions are listed in supplementary Table S1.
2.2. Cell Carrier Preparation
2.2.1. Human Amniotic Membrane. With ethical approval
from the UZA ethical committee (EC: EC: 14/30/319) and
signed written informed consent from donors, amniotic
membranes were obtained from women undergoing sched-
uled caesarean sections. HAM was cryopreserved and proc-
essed using previously described methods [34]. In brief, the
HAM was peeled away from the chorion and washed in
BSS containing penicillin/streptomycin and amphotericin
B. It was then ﬂattened onto a sterilized nitrocellulose ﬁlter
paper and cryopreserved at −80°C in 1 : 1 solution containing
DMEM and glycerol. The HAMwas thawed 48 hrs before use
and washed three times in saline, after which it was treated
with 50mL Thermolysin solution (0.12mg/mL) for 8min
to remove amniotic epithelium. After enzymatic digestion,
the membrane was washed in 0.01 M PBS after which orien-
tation of the membrane was tested with the previously
described 'cotton swab technique' [34]. When the
de-epetheliazed surface was identiﬁed to be superior, the
membrane was ﬁxed in an interlockable ring [34]. Prior to
primary cell cultivation, the HAM was immersed in the
respective culture medium containing 5% human AB serum
(hAB) for at least 24 hrs.
2.2.2. Recombinant Human Collagen Hydrogels. Plant-
derived RHC I was obtained as a solution in 10mM HCl. A
3 : 7 solution of pure (100%) ethanol/collagen was stirred
for 30min at 25°C, after which ﬁbrillogenesis buﬀer
(160mM Na2HPO4 and 100mM NaOH at pH7.5) was
added at a ratio of 1 : 10 v/v to the original collagen-HCl vol-
ume and stirred for 2 more hours. Water-diluted EDC and
NHS were added for a ﬁnal concentration of 50mM EDC
and 100mM NHS and stirred for 24 hrs at 4°C. All stirring
was performed using a magnetic stirrer at 200 rpm. After
24 hrs, excess EDC/NHS was washed out with DW in 6
cycles. One cycle consists of centrifugation at full speed
(10min, 5.000 rpm), discarding the supernatant and resus-
pending the collagen in 40mL DW. At cycle 6, the collagen
suspension was transferred to a Teﬂon mold and left air dry-
ing under a sterile hood. When fully dried, collagen gels were
collected and stored in 100% ethanol until further use. Rehy-
dration of gels was performed by 5 individual washes in PBS,
each lasting 2 hrs. For cell cultivation, the hydrogels were
soaked thrice for 2 hrs in the respective culture medium
and immobilized with a CellCrown or interlockable ring.
2.2.3. Collagen-Like Peptide Hydrogels. CLP peptide synthe-
sis, conjugation with PEG maleimide, and CLP-PEG hydro-
gel fabrication were described in the study of Islam et al.
[21]. Brieﬂy, 500mg of aqueous solution of 18% or 12%
(w/w) CLP-PEG was dispensed in a 2mL glass syringe, and
either EDC/NHS or DMTMMwas added to the syringe mix-
ing system. The molar equivalents of CLP-PEG-NH2 : EDC
were 1 : 2 and the molar ratio of EDC :NHS was 1 : 1. For
CLP-PEG-NH2 :DMTMM, the molar ratio was 1 : 2. All
reagents were thoroughly mixed prior to casting the hydrogel
into thin ﬂat sheets. Alternatively, the hydrogel was molded
in a PDMS mold with a surface topography of 50μm wide
and 20μm deep grooves. All CLP-PEG hydrogel sheets were
cut into 15mm diameter disks using a trephine and kept in a
PBS buﬀer. Hydrogel sheet thickness and the groove topogra-
phy were measured using an Olympus BX51 upright micro-
scope equipped with a Peltier-cooled Fview II CCD camera
(Olympus, Tokyo, Japan).
Prior to cell cultivation, CLP hydrogels were soaked in
respective culture medium for 96 hrs (4 days). CLP hydrogels
did not require ﬁxation to allow cell cultivation.
2.2.4. Surface Micropatterning. RCH I hydrogels were rehy-
drated in PBS and cut into approximately 20 × 25mm2 sized
pieces. Microcontact printing (μCP) onto RHC I and CLP
hydrogel surfaces was carried out as described previously
[21]. Brieﬂy, native surface carboxyl groups of RHC I and
CLP-PEG hydrogels were activated by applying 10mM
EDC and 2.5mM NHS in 0.1M PBS (pH5.7) for 15min.
The hydrogels were then washed with fresh PBS (pH5.7).
The surface of each sample was dried in a N2 stream, keeping
the material bulk hydrated. Stamps were made of PDMS,
with rectangular stamps (~16 × 23mm) used for RHC I and
12mm diameter disks for CLP-PEG printing. The stamps
contained surface topography of protruding 30μm wide
stripes with 60μm spaces in between. They were inked by
applying 0.1mg/mL human blood ﬁbronectin solution for
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5min. For pattern visualization, ink contained 0.01mg/mL of
HiLyte488 dye-marked ﬁbronectin. After inking, the PDMS
stamp was brought into contact with the activated and dried
hydrogel surface for 5min. Subsequently, the remaining
unreacted hydrogel surface was passivated by applying
10mM PEG3NH2 (Molecular Biosciences, Boulder, CO,
USA). The samples were washed with fresh PBS (pH8.0)
buﬀer and stored at 4°C until further use.
To investigate reproducibility of F-μCP patterning,
the patterned hydrogels were imaged using an Olympus
BX51 upright microscope. Fluorescence images of
ﬁbronectin-HiLyte488 patterns were acquired and analyzed
using the Stream Motion software (Olympus). Fibronectin
pattern quality was assessed manually, using stitched ﬂuores-
cence microscopy images taken over the entire printed
hydrogel surface area. Then the actual printed surface area
was calculated by subtracting any defects from the total
area occupied by the surface topographic features on the
PDMS stamp.
An overview of hydrogel composition and their respec-
tive abbreviation is provided in Table 2. HAM serves as a
control. Hydrogels are (1) unmodiﬁed RHC I, (2) RHC I that
was F-μCP (RHC I F-μCP), (3) EDC/NHS-crosslinked CLP
(CLP-12 EDC), (4) DMTMM-crosslinked CLP (CLP-12),
(5) CLP-12 with surface F-μCP (CLP-12F-μCP), (6)
CLP-12 with 3D-grooved surface topography (CLP-12 3D),
(7) and DMTMM-crosslinked CLP at a CLP stock concentra-
tion of 18% (CLP-18).
2.3. Cell Cultivation
2.3.1. Immortalized Corneal Epithelial Cell Cultivation. For
in vitro biocompatibility testing, immortalized human cor-
neal epithelial cells (iHCECs) [35] were seeded onto the
membranes and cultivated in keratinocyte serum-free
medium. Cells were cultured in a humidiﬁed 37°C (5%
CO2) incubator. To perform live cell imaging, green ﬂuores-
cence protein- (GFP-) transduced iHCECs (GFP-iHCECs)
[21] were cultured using the same cultivation protocol.
2.3.2. Primary Limbal Epithelial Cell Cultivation. Cadaveric
donor eyes were collected from the cornea tissue bank of
the Antwerp University Hospital. The donor age ranged from
49 to 90 years with an average of 74 years. All donor eyes
were processed within 32 hrs postmortem. In brief, the eyes
were enucleated, transferred in 0.9% NaCl, and stored at
4°C. The eyes were disinfected for 1min in povidone iodine
0.5%, after which they were rinsed 4 times in PBS. Biopsies
of ≤2mm2 were taken from the superior and inferior kerato-
limbal regions and washed 6 × 10 min in CnT-PR (CELLn-
TEC) at 4°C. Biopsies were then placed epithelial side down
on the tested carrier materials (Table 2) and cultivated for
14 days at 37°C, 5% CO2, and 95% humidity. For cultivations
on HAM and RHC I, 1% hAB was added to culture medium.
Culture medium was changed every other day. The ﬁrst 3
days, cells were cultivated at an air-liquid interface to allow
biopsy attachment. Onwards, volume of the medium was
increased to submerge cultures. At day 14 (or earlier if con-
ﬂuent), cells were characterized through immunohistochem-
istry and reverse transcriptase PCR (RT-PCR) analyses.
2.4. In Vitro Biocompatibility Testing. To assess in vitro bio-
compatibility of collagen-based hydrogels, samples of 6mm
diameter were punched out of the membranes and placed
into 96-well plates. iHCECs were seeded onto the materials
at a density of 5000 cells per membrane (n = 3) and cultured
up to 4 days (96 hrs). Cell cultures on HAM served as a con-
trol. At 24hrs, 48 hrs, 72 hrs, and 96 hrs of cultivation, a Pre-
stoBlue cell metabolic activity assay was performed according
to the manufacturer’s protocol. In brief, PrestoBlue was
added (1 : 10 v/v) to the cultures and incubated for 35
minutes. The supernatant was transferred to an opaque
96-well plate, and ﬂuorescence was read at 590nm with
VICTOR3. Supplementary Live/Dead staining was per-
formed at 48hrs of cultivation, where cells were double
stained with calcein acetoxymethyl (Calcein AM) and ethi-
dium homodimer-1 (EthD-1). Cells cultured on tissue cul-
ture plastic (TCP) and treated with 0.1% saponin for
20min at 37°C were used as positive controls for EthD-1.
For PrestoBlue analysis, independent nonparametric t-test-
ing was performed using the SPSS 24 Kruskal-Wallis test
(IBM Corp., NY, USA) and Prism 5 (GraphPad Software,
CA, USA). p < 0 05 was considered signiﬁcant.
To evaluate the pattern of proliferation, live cell imag-
ing of GFP-iHCECs [21] was performed. Hydrogel sam-
ples of 15mm diameter were placed into 12-well plates.
RHC I hydrogels were ﬁxated with CellCrown inserts.
GFP-iHCECs were seeded onto the materials at a density
of 10.000 cells per membrane. Live cell imaging was per-
formed in an incubator that was mounted on a confocal
Table 1: Oligonucleotide primers and primers used for reverse transcriptase PCR.
Gene name Gene symbol Assay ID
Glyceraldehyde-3-phosphate dehydrogenase GAPDH qHsaCED0042632
β-2-Microglobulin B2M qHsaCED0015347
ΔNp63α [37] ΔNp63α Fw: GCATTGTCAGTTTCTTAGCGAG
Rev: CCATGGAGTAATGCTCAATCTG
Cytokeratin 3 KRT3 qHsaCID0005917
Desmoglein 3 DSG3 qHsaCID0015226
Integrin-β1 INTB1 qHsaCED0005248
Integrin-α6 INTA6 qHsaCED0042632
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laser scanning microscope (Eclipse Ti microscope, Nikon,
Tokyo, Japan; UltraVIEW VoX, PerkinElmer). The micro-
scope recorded images at 90-minute intervals for 3 days
(72 hrs). Images obtained at 72hrs of culture were ana-
lyzed with ImageJ (National Institutes of Health, Bethesda,
MD, USA) to calculate the percentage area of conﬂuence.
Of each culture condition, images of 6 diﬀerent sites were
analyzed. To detect statistical signiﬁcance, independent
nonparametric t-testing was performed using the
Mann-Whitney U test in Prism 5 (GraphPad Software,
CA, USA). Live cell imaging was not performed for
HAM as the composite graft was not compatible with
the microscope setup.
After 72 hrs of imaging, cells were kept in culture until
day 4, when samples were ﬁxed in 2.5% glutaraldehyde solu-
tion in 0.1M sodium cacodylate buﬀer (pH7.4), and proc-
essed for scanning electron microscopy (SEM) and
transmission electron microscopy (TEM).
2.5. Electron Microscopy
2.5.1. Scanning Electron Microscopy. For SEM, ﬁxed samples
were rinsed in 7.5% saccharose in 0.1M cacodylate buﬀer,
pH7.4, and then dehydrated through an ascending ethanol
gradient (50% ethanol 10min; 70% - 90% - 95% ethanol
15min each; 100% ethanol 3 × 30 min). After critical point
drying, samples were mounted on a SEM grid and shutter
coated with 20nm gold. Images were recorded with a SEM
515 Microscope (Philips, Eindhoven, the Netherlands).
2.5.2. Transmission Electron Microscopy. Samples were post-
ﬁxed in 1% OsO4 solution and dehydrated in an ethanol gra-
dient (50% - 70% - 90% - 95% ethanol for 15min each, 100%
ethanol for 4 × 20 min). Samples were embedded in EMbed
812 (Electron Microscopy Sciences, Hatﬁeld, Pennsylvania),
sectioned, and stained with lead citrate. Slides were examined
using a Tecnai G2 Spirit BioTWINMicroscope (FEI, Eindho-
ven, the Netherlands) at 120 kV.
2.6. Characterization of Primary LESC Cultures
2.6.1. Immunohistochemistry. For immunohistochemistry,
cultures were ﬁxed in 100% ethanol for 10min at -20°C and
rinsed thrice in PBS for 10min each. Samples were embedded
in OCT compound and stored at -80°C. Five cryostat sections
(13μm thick) of each sample were mounted on poly-L-lysi-
ne-coated microscope slides, dried at 37°C for 2 hrs, and
processed for ﬂuorescence immunolabeling. Sections were
then permeabilized with Triton X 1% for 25min. Primary
antibodies were incubated overnight at 4°C. Anti-ΔNp63,
anti-cytokeratin 3 (KRT3), anti-laminin, anti-KRT14,
anti-collagen type IV (Coll-IV), anti-integrin-β4 (INTB4),
anti-desmoglein 3 (DSG3), and anti-E-cadherin (E-cad)
served as primary antibodies (supplementary Table S1).
Fluorescent secondary and tertiary antibody labeling was
incubated for 2 hrs at 4°C. Nuclei were counterstained using
DAPI, and sections were mounted with Citiﬂuor. Images
were recorded with confocal microscopy.
2.6.2. RNA Extraction, Reverse Transcription, and Polymerase
Chain Reaction. Prior to RNA extraction, cultures were
rinsed once with 0.1M PBS, preheated at 37°C. Cells were
incubated with RNA lysis buﬀer, and total cell RNA was
extracted, following RNeasy Mini Kit-enclosed guidelines.
Total RNA was diluted in 14μL water, and purity was evalu-
ated from the 260/280 ratio of absorbance (1.80–2.00) using
the NanoDrop™ spectrophotometer (Thermo Fischer Scien-
tiﬁc). cDNA was synthesized from 10μL of total RNA using
iScript™ Advanced cDNA Synthesis kit and CFX96™ ther-
mocycler (Bio-Rad), according to the manufacturer’s proto-
col. cDNA was diluted to a 10ng/μL concentration and
frozen down (-20°C) until further use. PCR assays were per-
formed from 10ng of cDNA in SsoAdvanced Universal
SYBR Green Supermix on the CFX96™ thermocycler with
the following settings: an activation step of 30 seconds at
95°C and 40 ampliﬁcation cycles of denaturation (95°C for
5 sec) and annealing/extension (60°C for 30 sec). Oligonucle-
otide primers that were used are listed in Table 1. All samples
were run in duplicate. To conﬁrm their ampliﬁcation speci-
ﬁcity, the PCR products were subjected to a melting curve
analysis. A nontemplate control was included in all experi-
ments, and the GAPDH gene was used as endogenous con-
trol for normalization. The comparative cycle threshold
(Ct) method, where the target fold = 2−ΔΔCt, was used to ana-
lyze the results [36]. Primary LESC cultured on TCP in
Table 2: Tested carrier material.
Abbreviation Material Crosslinker Surface patterning Collagen concentration∗
HAM Denuded HAM — — —
RHC I RHC I EDC/NHS — ~3mg/cm2
RHC I F-μCP RHC I EDC/NHS Fibronectin microcontact printing ~3mg/cm2
CLP-12 EDC CLP-PEG EDC/NHS — 12%
CLP-12 CLP-PEG DMTMM — 12%
CLP-12F-μCP CLP-PEG DMTMM Fibronectin microcontact printing 12%
CLP-12 3D CLP-PEG DMTMM 3D topography 12%
CLP-18 CLP-PEG DMTMM — 18%
∗Concentration of RHC I is expressed as net weight at collagen casting (mg/cm2). Concentration of CLP is expressed as percentage of stock solute (%).—: not
applicable; HAM: human amniotic membrane; RHC I: recombinant human collagen type I; CLP-PEG: PEGylated collagen-like peptide; EDC:
1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide; NHS: N-hydroxysuccinimide; DMTMM: 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium
chloride.
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12-well plates served as the calibrator controls and had an
assigned value of 1. The results were reported as a fold upreg-
ulation or fold downregulation when the fold change was
greater or less than 1, respectively. Cultures from four diﬀer-
ent donor corneas were analyzed for each type of hydrogel.
As cultures on hydrogels had a donor-matched culture on
HAM, 6 donors were included for HAM analysis.
For statistical analysis, a linear mixed model was ﬁtted to
account for the nonindependence between observations
within the same hydrogel (i.e., interdonor variation). Within
this model, gene expression served as a dependent variable,
the hydrogel group as an independent variable, and the
donor cornea as a random intercept. The signiﬁcance of the
ﬁxed eﬀect, testing the null hypothesis that the mean out-
come is the same across diﬀerent culture substrates within
one donor, was tested using an F-test with Kenward-Roger
correction for the degrees of freedom. When signiﬁcance of
the ﬁxed eﬀect was observed, a post hoc analysis was carried
out with a Tukey correction for multiple comparison.
3. Results
3.1. Hydrogel Production and Surface Modiﬁcation. All
hydrogel manufacturing protocols resulted in the successful
production of hydrogels that were mechanically robust.
Thickness values of collagen hydrogels which varied between
groups were as follows: 133 ± 28 μm for RHC I, 500 ± 50 μm
for CLP-12 EDC, 241 ± 98μm for CLP-12 (including CLP-12
F-μCP), 303 ± 91 μm for CLP-12 3D, and 244 ± 90μm for
CLP-18 hydrogels. We can now conﬁrm that thin RHC I
and CLP-12 membranes can successfully undergo F-μCP
(Figure S1), with the quality of surface patterns being
higher for CLP (75%±6) than RHC I (40%±28) hydrogels.
Surface topography on CLP hydrogels was deemed
successful as hydrogels remained intact and displayed a
groove width close to 49 ± 2 μm on bright ﬁeld microscopy.
Physical characterization (Table 3; supplementary data
“physical characterization of carrier membranes—Fig. S2”)
shows that water content (%) of collagen hydrogels varied
between 88% and 93%, indicating that the type of collagen,
type of crosslinker, and percentage of CLP did not make
much of a diﬀerence. Light transmittance of collagen hydro-
gels was much higher than that of HAM, with values being
comparable to those of native corneas. Transparency of
CLP hydrogels (≥91%) was higher than that of RHC I hydro-
gels (84 8 ± 1 45). The refractive index of collagen hydrogels
(1.34 – 1.35) was closer to that of the human cornea
(1.37-1.38) compared to HAM (1.33). Permeability of the
hydrogels was comparable to that of HAM, the currently
used gold standard.
3.2. In Vitro Biocompatibility Testing of Hydrogels. In the ﬁrst
set of experiments, iHCECs were cultured on diﬀerent sub-
strates and cell metabolic activity was monitored. PrestoBlue
assay (Figure 1) revealed that cell metabolic activity was com-
parable for each of the substrates. Supplementary Live/Dead
staining performed at 48 hrs postculture conﬁrmed the bio-
compatibility of collagen hydrogels as cells exhibit minimal
cell death on the hydrogels and comparable or lower cell
death than HAM (Figure S3).
Live cell imaging conﬁrmed that both RHC I and CLP
hydrogels, regardless of surface modiﬁcation, supported
attachment and proliferation of cells (Figure 2). Cells were
found to attach to the respective hydrogel 3 hrs after seeding,
which was comparable between hydrogel groups. F-μCP
appeared to inﬂuence cell proliferation on CLP hydrogels,
unlike on RHC I hydrogels, as cells seemingly ﬁrst attached
to ﬁbronectin stripes before populating the rest of the CLP
hydrogel (Figure 2(b)). For CLP-12 3D, cells showed to pref-
erentially grow ﬁrst in the grooves, prior to spreading over
the hydrogel’s ridges (Figure 2(b)). At 72hrs of culture, cells
cultivated on CLP DMTMM hydrogels showed cell a conﬂu-
ence of ≥80% with an average conﬂuence of 91 0%±1 3 for
CLP-12, 85 0%±3 3 for CLP-12 F-μCP, 90 0%±2 7 for
CLP-12 3D, and 89 6%±1 2 for CLP-18 (Figure 2(c)). The
average conﬂuence of RHC I and RHC I F-μCP was
71 4%±4 1 and 66 27%±8 3, respectively, with RHC I
showing signiﬁcantly less conﬂuence compared to any of
CLP DMTMM hydrogels and RHC I F-μCP being less con-
ﬂuent then CLP-12, CLP-12 3D, and CLP-18 (Figure 2(c)).
The lowest average conﬂuence was observed for CLP-12
EDC (65 1%±18 3), with 2 sites showing a conﬂuence
of <10% (data not shown).
After 4 days of cultivation, SEM imaging (Figure 3) was
performed at regions that had reached full conﬂuence. Cul-
tured cells displayed the typical cobblestone appearance;
however, at RHC I hydrogels, some isolated cells displayed
an elongated morphology. In a region where cells had not
reached full conﬂuence on CLP-12 3D hydrogels, cells were
mainly observed in the grooves and not on the ridges of the
hydrogel. TEM imaging (Figure 4) of cultures conﬁrmed
that a monolayer of cells had formed on all substrates
and that cells displayed apical microvilli. Furthermore, it
was noted that cells cultivated on collagen hydrogels had
not initiated diﬀerentiation, whereas cells cultivated on
HAM expressed gap junctions in the absence of stratiﬁca-
tion, indicating early diﬀerentiation.
3.3. Cultivation and Characterization of Primary LESC
Cultures. A total of 41 eyes of 22 donors, with an average
donor age of 73 7 ± 11 3 years (range 49-90 years), were used
for this study. Cultured epithelial cells were analyzed every 2
days with phase contrast microscopy (Figure 5). By day 3 of
culture, epithelial cells had emerged from 83% of limbal biop-
sies. Explants that did not prove successful by day 3 did not
display cell outgrowth later. No signiﬁcant diﬀerence for suc-
cessful initiation of explant cultivation was observed between
diﬀerent substrates (data not shown). During the ﬁrst week of
cultivation, cells that were cultivated on the surface of the
modiﬁed CLP hydrogels displayed a distinctive proliferation
pattern (Figure 5(a)). In accordance with the observations
made at live cell imaging, pioneer cells followed ﬁbronectin
patterns, colonizing the intermediate area in the following
hours and days. Similarly, cells on 3D hydrogels grew ﬁrst
in the grooves before expanding over the ridges. On day 14
of culture (Figure 5(b)), outgrowth on all substrates con-
tained small and cuboidal epithelial-like cells of varying cell
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size. Cells cultured on HAM maintained a smaller round
shape compared to cells cultivated on hydrogels. In contrast,
cells cultured on RHC I and RHC I F-μCP displayed a more
heterogeneous morphology with singular elongated cells
being observed in between simple squamous epithelial cell
growth. By day 14, all cultures on CLP DMTMM hydrogels
had reached near conﬂuence on the 15mm diameter gel. In
contrast, none of the CLP-12 EDC hydrogels reached conﬂu-
ence; moreover, 3 out of 9 cultures generated too low cell
yield for further characterization and 5 out of 9 cultures did
not meet the minimum 8mm diameter outgrowth, which is
deemed a quality standard at our center. At day 14, RHC I
and RHC I F-μCP cultures displayed an average cellular out-
growth of >15mm, whereas HAM cultures had reached sub-
conﬂuence in a 14-15mm diameter.
3.3.1. Immunohistochemical Characterization
(1) Expression of Stem Cell Markers. The stemness of culti-
vated cells was veriﬁed with ΔNp63 and KRT14 (Figure 6).
Both markers have been attributed to progenitor epithelial
cells in the basal and suprabasal layers of the limbus
[38–40]. Cells cultivated on any of the substrates showed
nuclear staining of ΔNp63 and cytoplasmic staining of
KRT14. No immediate diﬀerence in the pattern of expres-
sion was observed between diﬀerent substrates.
(2) Expression of Diﬀerentiation Markers. KRT3 and DSG3
were used as diﬀerentiation markers for corneal epithelial
cells. KRT3 is a cytoplasmic keratin that has been shown to
be speciﬁc for corneal epithelium [41], and DSG3 is a glyco-
protein component of desmosomes [42, 43]; both markers
display diﬀerentiation-related expression. Cultivated cells
showed low expression of bothmarkers, with only few isolated
cells that were KRT3 or DSG3 positive. Double staining with
ΔNp63 conﬁrmed that DSG3-positive cells lacked expression
of the stem cell marker (Figure 6—HAM). Pattern of expres-
sion was comparable between tested scaﬀolds.
(3) Expression of Extracellular Matrix Proteins and Cell Adhe-
sion Markers. Laminin and Coll-IV have been described as
extracellular matrix and basement membrane components of
the human cornea and limbus [42, 44]. Extracellular expres-
sion of both markers was noted, indicating deposition of lam-
inin and Coll-IV by cultivated cells on the respective substrate
(Figure 6). Coll-IV also is a key component of HAM [45],
which is shown by the Coll-IV-positive staining of HAM
stroma (Figure 6). INTB4 and E-cad have been proposed to
mediate cell anchorage of basal epithelial cells, with INTB4
expression being conﬁned to LESC [43, 46] and E-cadherin
expression being more speciﬁc for basal and suprabasal cor-
neal epithelial cells [47]. Both markers show positive mem-
brane expression in cultivated cells. INTB4 expression
appears to be conﬁned to the basal side, whereas E-cad expres-
sion is more diﬀuse and is expressed in the cytoplasm and at
the basal and apical sides. No apparent diﬀerence in the pat-
tern of expression was noted between the tested substrates.
3.3.2. Gene Expression of Limbal Epithelial and Corneal
Epithelial Cell Makers. With the house keeping gene,
GAPDH, as an internal control and cell cultures on TCP as
a calibrator, RT-qPCR showed positive expression for
ΔNp63α, KRT3, DSG3, INTB1, and INTA6 (Figure 7). Integ-
rin-β1 and integrin-α6 are known to be progenitor
cell-speciﬁc adhesion proteins [43]. A statistically signiﬁcant
diﬀerence between groups was only observed for KRT3
expression (Figure 7), with RHC I, RHC I F-μCP, and
HAM showing signiﬁcantly lower expression levels com-
pared to CLP hydrogels. More speciﬁcally, signiﬁcantly lower
KRT3 expression was noted for RHC I when compared to
any of the CLP hydrogels, whereas lower expression was
noted for RHC I F-μCP when compared to CLP-12 F-μCP,
CLP-12 3D, and CLP-18 and for HAM when compared to
CLP-18. Furthermore, a trend (p ≤ 0 1) was observed for
lower KRT3 expression in HAM than in CLP-12 F-μCP
and CLP-12 3D and in RHC I F-μCP than in CLP-12.
The relative fold change in gene expression is listed as
supplementary data (Table S2).
Table 3: Properties of RHC I, CLP-12 EDC, and CLP DMTMM hydrogels, with HAM and the human cornea serving as control.
Properties HAM RHC I CLP-12 EDC CLP-12 CLP-18 Human cornea
Water content (%) 87 68 ± 0 02 89 21 ± 0 01 91 65 ± 1 10 [28] 90 31 ± 0 02 88 42 ± 0 01 78 [39]
Refractive index 1.33 1.35 1.34 [27] 1.35 1.35 1.37-1.38 [40]
Transmission at 490 nm (%) 60 0 ± 2 2 84 8 ± 1 5 92 4 ± 1 0 [28] 91 0 ± 0 8 91 0 ± 0 5 87 1 ± 2 0 [41]
Apparent permeability (Papp) (cm/sec) 0 039 ± 0 007 0 057 ± 0 03 0 061 ± 0 003 0 056 ± 0 006 0 047 ± 0 006 NA
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Figure 1: In vitro biocompatibility of collagen hydrogels. PrestoBlue
viability assay showed that for all substrates, cumulative cell viability
of iHCECs was similar at days 1, 2, and 3 of culture.
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4. Discussion
CLET has been a major breakthrough for the treatment of
patients suﬀering from LSCD [4, 5, 14]. However, protocols
for LESC cultivation need further optimization and stan-
dardization as they commonly involve animal-derived sup-
plements, such as growth factors, serum, and/or ﬁbroblast
feeder layers [48], all of which could induce zoonosis, allergy,
and other side eﬀects [49]. In the context of GMP regulations,
both stem cell carrier and culture protocol should meet strict
guidelines in quality. Attempts have been made to remove
xenogeneic products from culture protocols [5, 50, 51] in
order to achieve standardization. Standardizing HAM, the
carrier material most frequently used in CLET, remains
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Figure 2: Cell growth of GFP-iHCECs on collagen hydrogels. (a) Representative images of cells cultivated for 36 hrs on RHC I, RHC I F-μCP,
CLP-12 EDC, CLP-12, and CLP-18 demonstrate that cells proliferate in a random pattern. (b) Micrographs of cultures on surface-modiﬁed
CLP-12 F-μCP and CLP-12 3D at 12 hrs, 24 hrs, 36 hrs, and 48 hrs. Cells cultured on surface-modiﬁed CLP hydrogels display a proliferation
pattern that is being inﬂuenced by the ﬁbronectin striping and 3D grooving. Orientation of F-μCP stripes is shown with a double white arrow.
Grooves of CLP-12 3D hydrogels are marked by white asterisk (∗). (c) The area of conﬂuence at 72 hrs of culture. RHC I hydrogels displayed
less conﬂuence when compared to any of the CLP DMTMM hydrogels. RHC I F-μCP showed less conﬂuence when compared to CLP-12,
CLP18%, and CLP-12 3D. ● and ●●● indicate p < 0 05 and p < 0 005, respectively, as compared to RHC I. ◆p < 0 05 as compared to
RHC I F-μCP.
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challenging as it is characterized by considerable variation in
physicochemical properties [10–13].
CLP and RHC I both originate from xeno-free sources
and are optically transparent, mechanically stable, and bio-
compatible in vivo [27, 28]. CLP-12 EDC hydrogels have
shown great promise as an acellular corneal construct
in vivo [27, 28]. However, EDC/NHS crosslinking is too fast
to allow successful casting and production of thin hydrogels
(<300μm thick) [52]. To generate a ﬂexible and thin scaﬀold,
we used DMTMM as an alternative crosslinker. Other
groups have demonstrated the eﬃciency of DMTMM over
EDC/NHS for crosslinking of peptides and glycosamino-
glycans as DMTMM resulted in slower crosslinking time
and hence more homogenous hydrogels [53]. Similar to
EDC/NHS, DMTMM is a zero-length crosslinker, imply-
ing that it is not incorporated into the scaﬀold. DMTMM
has the advantage of not requiring pH control or cause
pH shift during the reaction over EDC/NHS, ensuring
good reaction yields and biocompatibility [53, 54]. In this
study, we used DMTMM to crosslink collagen derivatives
[55] and tested its in vitro performance. RHC I was not
crosslinked with DMTMM since our previous research
demonstrated that EDC/NHS-crosslinked RHC I gels were
of desired thickness (<150μm thick) and ﬂexibility.
Our data demonstrate that RHC I and CLP hydrogels,
irrespective of type of crosslinker, support cultivation of
iHCECs and primary limbal epithelial cells. CLP-12 EDC,
however, was the only tested carrier material for which pri-
mary limbal epithelial cultures did not meet quality stan-
dards due to low cell yield. Interestingly, our previous data
indicate that CLP-12 EDC might be a suitable acellular alter-
native to conventional corneal transplantion [27]. In the
work of Jangamreddy et al., we noted that suboptimal growth
of iHCECs at days 1 and 2 on CLP-12 EDC hydrogels does
not necessarily translate into inferior in vivo performance
[27]. After all, acellular CLP-12 EDC corneas supported
functional reepithelialization when implanted in pigs. More-
over, CLP implants performed equally with RHC III-based
hydrogels, of which the latter have successfully been
implanted in humans [18, 20]. Nonetheless, we have now
shown that CLP-12 EDC is less suitable for standardized
in vitro cultivation of primary limbal epithelium. Conversely,
RHC I hydrogels did meet quality standards of cell outgrowth
for primary limbal cultures, although signiﬁcant lower con-
ﬂuence was observed for iHCEC cultures compared to CLP
DMTMM hydrogels after 3 days of cultivation. This discrep-
ancy might be explained by the fact that iHCECs display a
signiﬁcantly altered genomic proﬁle to primary limbal epi-
thelium [56]. This must be carefully considered when draw-
ing conclusions on data obtained through their use.
In our experiments, surface modiﬁcation of RHC I
did not inﬂuence pattern of cell proliferation, which
40 mm 10 mm 10 mm
10 mm 10 mm 10 mm
10 mm 10 mm 10 mm
CLP-12 3D CLP-18
CLP-12 EDC CLP-12 CLP-12 F-mCP
RHC I F-mCPHAM
CLP-12 3D
RHC I
Figure 3: SEM imaging of iHCECs cultivated on HAM and collagen hydrogels for 4 days. Cells had formed a conﬂuent monolayer. In general,
cells exhibited a typical cobblestone appearance. At a region where cells had not reached full conﬂuence on CLP-12 3D (lower middle), cells
were mainly present in the grooves.
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might be attributed to the inherent biocompatibility of RHC
[18–21, 27, 31, 32, 57, 58]. Even though surface modiﬁcation
of CLP DMTMM hydrogels inﬂuenced the pattern of cell
proliferation, the rate of outgrowth and the genotype and
phenotype of cultured cells were not signiﬁcantly altered. It
can therefore be assumed that surface patterning of RHC I
and CLP DMTMM hydrogels may be unnecessary to attain
successful LESC-enriched cultures in vitro. Our results con-
ﬁrm the ﬁndings of Hogerheyde et al. [59], in which ﬁbronec-
tin coating of silk ﬁbroin membranes did not signiﬁcantly
improve cell outgrowth of iHCECs or of primary LESC. Con-
versely, our results are in contradiction to previous research
that showed the beneﬁt of ﬁbronectin patterning of carrier
membranes on cell proliferation of iHCECs [21, 60]. In the
study of Islam et al., a similar ﬁbronectin patterning protocol
was used as that in our study; however, the membrane of
interest was RHC III-MPC and anti-Ki67, anti-focal adhe-
sion kinase, and anti-integrin-β1 were used as antibodies in
immunohistochemical characterization [21].
In 2013, the group of Levis et al. introduced RAFT (Real
Architecture for 3D Tissue) hydrogels, a collagen construct
produced through plastic compression of bovine type I colla-
gen, as an in vitromodel of the human cornea [61]. To mimic
limbal crypts, 3D grooves were created in the hydrogel’s sur-
face (RAFT TE). RAFT TE successfully support limbal epi-
thelium cultivation; however, clinical impact is limited since
RAFT lacks chemical crosslinking and thus results in hetero-
geneous hydrogels with suboptimal optical and mechanical
properties [61–63]. Furthermore, biocompatibility of RAFT
gels has yet to be validated in vivo.
1 mm 200 nm 1 mm
‡ ‡
1 mm
‡‡ ‡
1 mm1 mm
1 mm 1 mm1 mm
‡‡ ‡
HAM HAM RHC I
CLP-12 F-mCP CLP-18CLP-12 3D
RHC I F-mCP CLP-12 EDC CLP-12
Figure 4: TEM micrographs of iHCECs on diﬀerent substrates after 4 days of cultivation. A conﬂuent monolayer had formed, in which cells
displayed multiple interdigitations and apical microvilli (inset). Cells cultivated on HAM displayed expression of gap junctions (middle top),
whereas cells cultivated on collagen hydrogels had not initiated diﬀerentiation as desmosomes, hemidesmosomes, and gap junctions could not
be observed. ‡ denotes the carrier material.
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When compared to our study, aforementioned reports
[21, 59–62] lacked (i) extensive phenotyping and genotyping
of cultured primary cells, (ii) comparison to HAM, the
carrier of choice in CLET, and/or (iii) implementation
of a xeno-free, standardized cultivation protocol; all of
which indicate further need of optimization-described
techniques.
To the best of our knowledge, we are the ﬁrst to cultivate
primary human limbal epithelium on collagen hydrogels
using a xeno-free and fully standardized culture protocol.
The CnT-PR medium is a GMP-grade culture medium that
has been selectively developed to target progenitor cells of
epithelial lineage and to inhibit proliferation of cells from
mesenchymal lineage [50, 64]. By using a GMP-grade culture
medium, the proposed cultivation protocol could be trans-
lated into a clinical setting with relative ease. In our setup,
primary cells grew to conﬂuence within 14 days of culture,
except for CLP-12 EDC, without the addition of 3T3 feeder
layers or xenobiotics. RHC I hydrogels could only success-
fully support primary cells when 1% hAB was added to the
culture medium. For CLP hydrogels, a serum-free culture
medium was attained but hydrogels had to be soaked for at
least 4 days in culture medium to consistently demonstrate
explant outgrowth (data not shown).
Immunostaining revealed that cultured cells show low
expression of diﬀerentiation markers KRT3 and DSG3 and
high expression of progenitor marker ΔNp63, proliferation
marker KRT14, and adhesion markers INTB4 and E-cad.
Furthermore, cells deposited extracellular matrix and base-
ment membrane proteins laminin and Coll-IV. This pattern
of protein expression strongly suggests that cells cultured
on any of the carriers can be identiﬁed as LESC [38–43, 46,
65]. E-cad expression remained largely cytoplasmic, with cell
membrane localization to a certain extent. This pattern of
staining shows that E-cad expression had not reached a
maximum, indicating that cells were in a relatively undiﬀer-
entiated state. In vitro supplementation with CaCl2
(Figure S4) shows that E-cad expression is located mainly at
the cell membrane when cells are initiating diﬀerentiation.
Even though a nonspeciﬁc ΔNp63 antibody was used for
CLP-12 F-mCP CLP-12 3D
200 mm
(a)
HAM RHC I RHC I F-mCP CLP-12 EDC
CLP-12 CLP-18CLP-12 F-mCP CLP-12 3D
200 mm
200 mm
(b)
Figure 5: Representative images of primary limbal epithelial cell cultures at day 4 (a) and day 14 (b) on various carrier materials. At day 4, it is
evident that surface modiﬁcation of CLP hydrogels inﬂuences limbal epithelial cell outgrowth, as cell ﬁrst grew on ﬁbronectin stripes or in
grooves, before spreading over the rest of the hydrogel growth. By day 14, cell conﬂuence was reached in a 15mm diameter outgrowth on
both types of RHC I gel, all types of CLP DMTMM gel, and HAM. After 14 days, cells on CLP-12 EDC had not reached full conﬂuence.
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immunohistochemistry that targeted all three ΔNp63
isoforms (α, β, and γ), previous work from Di Iorio et al.
[39] indicated that LESC strictly contain the α-isoform and
not β- or γ-isoforms. Diﬀerentiated corneal epithelium on
the other hand does not contain any of the isoforms. In
PCR analysis, a speciﬁc ΔNp63α primer was used.
Apart from KRT3, other markers that were targeted with
RT-PCR have shown comparable expression between diﬀer-
ent groups. In general, a signiﬁcant diﬀerence in relative
expression of KRT3 between CLP and RHC I hydrogels was
observed, with the RHC group showing lower expression.
KRT3 expression levels for CLP hydrogels are well below
levels observed for corneal epithelium (>2500; data not
shown) or in vitro-diﬀerentiated limbal epithelial cells
(Figure S4). Placing gene expression patterns into the
perspective of diﬀerentiated cells indicates that all hydrogels
perform extremely well, with RHC I slightly outperforming
CLP DMTMM. It is not clear whether lower KRT3
expression is inherent to RHC I hydrogels or must be
attributed to the adjusted culture protocol that involves 1%
hAB supplementation. Both our results and the data from
González et al. indicate that the concentration of hAB,
more than the carrier material, might inﬂuence the level of
diﬀerentiation [51]. Finally, it should be noted that KRT3
mRNA expression is relatively low (Cq value: 27-38)
compared to the other investigated markers (Cq: 21-27).
Therefore, mRNA expression might not be present in
suﬃcient quantities to promote protein expression, hence,
KRT3-negative IHC staining in LESC cultures. Data
obtained through in vitro diﬀerentiation conﬁrm this
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Figure 6: Immunohistochemistry of primary limbal epithelial cells cultured on diﬀerent carrier materials. Representative images of double
immunostaining for detection of ΔNp63-DSG3, laminin-KRT3, and Coll-IV-KRT14 and monostaining for detection of INTB4 and E-cad.
Overall, cultivated cells show high expression of (i) ΔNp63, a nuclear stem cell marker, (ii) KRT14, a cytoplasmic proliferation marker,
and (iii) laminin, Coll-IV, INTB4, and E-cad, markers of corneolimbal basal cell adhesion molecules and LESC niche-related extracellular
matrix. Low expression of proliferation markers DSG3 and KRT3 indicates that cultivated primary cells exhibit a LESC phenotype. All
stains were negative in hydrogel-only (no cell) control samples (data not shown).
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theory, as mRNA expression of KRT3 resulted in KRT3
protein detection (Figure S4).
Both primary cells and iHCECs were cultured in the
absence of airlifting andCaCl2 supplementation and therefore
did not initiate diﬀerentiation nor stratiﬁcation [66–68].
This may be regarded as a limitation of our study since
most methods used to establish limbal epithelial cultures
favor terminal diﬀerentiation over preservation of stemness
[69–71]. However, for long-term restoration of the dam-
aged ocular surface, preservation of LESC population may
be required during the culture process and postgrafting
[4, 39, 51, 66–68, 72–74]. Previous research using an
in vitro RAFT TE model concluded that airlifting was not
required to maintain a functional epithelium on collagen
hydrogels and that a higher yield of ΔNp63α-positive cells
was obtained in nonairlifted cultures [74]. In our study,
we provide evidence that cells cultivated in CnT-PR suc-
cessfully sustained their undiﬀerentiated LESC state, not
only on HAM [51] but also on collagen-based hydrogels.
Furthermore, cells cultivated in CnT-PR maintain their
ability to initiate diﬀerentiation, simply by adding 1.1mM
CaCl2 to the culture medium (Figure S4).
Finally, it should be stressed that collagen-based hydro-
gels are highly tunable, creating opportunities previously
unseen in CLET. Firstly, the thickness of collagen hydrogels
can be adjusted to tackle deeper corneal disease and thus
reduce the need for secondary corneal transplantation
post-CLET. This would be a considerable advantage over
other carrier materials such as HAM, silk ﬁbroin, siloxane
hydrogels, and ﬁbrin-coated contact lenses [4, 5, 75, 76]. Sec-
ondly, supporting niche cells such as limbal MSCs and mela-
nocytes could be incorporated into collagen hydrogels to
allow coculture of niche-related cells. Cocultures could play
an important role in the maintenance of a vast LESC side
population through improved mimicry of the native stem cell
niche [74, 77]. However, long-term survival of supporting
niche cells and possible clinical beneﬁt remain to be validated
in vivo. Thirdly, collagen hydrogels oﬀer additional opportu-
nities of surface patterning, which is a fully customizable pro-
cess. Even though our results did not indicate a short-term
beneﬁt for in vitro cultivation of LESC, surface patterning
might potentially result in an ideal microenvironment for
long-term LESC proliferation and preservation. In addition
to F-μCP and 3D fabrication, other groups have suggested
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Figure 7: Relative gene expression of stem cell markers (ΔNp63α), adhesion markers (INTB1, INTA6), and diﬀerentiation markers (KRT3,
DSG3) of primary limbal epithelial cells cultured on diﬀerent carrier materials. Statistical signiﬁcance (p ≤ 0 05) and statistical trends (p ≤ 0 1)
were noted only for KRT3 expression. •p ≤ 0 1; ∗p ≤ 0 05; ∗∗p ≤ 0 01; ∗∗∗p ≤ 0 001.
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surface tethering and bulk incorporation of laminin, collagen
type III, Coll-IV, IKVAV, YIGSR, RGD, and vitronectin [46,
59, 78, 79]. All of these possibilities support the promise of
collagen hydrogels in tissue engineering, not only in ophthal-
mology but also in other disciplines such orthopedics [80],
dermatology [81], and cardiology [82].
5. Conclusion
Based on our ﬁndings, we conclude that RHC I and CLP
hydrogels successfully support in vitro cultivation of iHCECs
and primary LESC. When compared to HAM, primary cell
cultivation on RHC I and CLP DMTMM hydrogels showed
comparable (i) cell outgrowth and (ii) ΔNp63α-positive cell
yield. We provide evidence that surface patterning, through
3D molding or F-μCP, inﬂuences cell attachment and cell
proliferation for CLP DMTMM hydrogels but not for RHC
I hydrogels. Our results indicate that surface patterning does
not impact the cell phenotype or genotype, but it could be
that the clinical signiﬁcance of surface patterning may only
become apparent in an in vivo setting. Finally, for reasons
unknown to us, CLP-12 EDC hydrogels resulted in subopti-
mal primary cell cultivation and underperformed when com-
pared to the other tested carriers. In conclusion, RHC I and
CLP DMTMM show promise in the cultivation of LESC
and contribute to the development of a culture protocol in
which both the carrier material and culturing technique are
xeno-free and fully standardized.
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